» Articles » PMID: 39352890

The Importance of IFNα2A (Roferon-A) in HSV-1 Latency and T Cell Exhaustion in Ocularly Infected Mice

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2024 Oct 1
PMID 39352890
Authors
Affiliations
Soon will be listed here.
Abstract

Published studies have generated compelling results indicating that type I IFN modulates function of HSV-1 latency-associated transcript (LAT). One member of type I IFN is IFNα2A also called Roferon-A). IFNα2A has been used in monotherapy or in combination therapy with other drugs to treat viral infections and different kinds of cancer in humans. The goal of this study was to determine whether the absence of IFNα2A affects primary and latent infections in ocularly infected mice. Therefore, we generated a mouse strain lacking IFNα2A expression (IFNα2A-/-). Ocular HSV-1 replication, IFN and immune cell expressions on days 3 and 5 post infection (PI), as well as eye disease, survival, latency-reactivation, and T cell exhaustion were evaluated in ocularly infected IFNα2A-/- and wild type (WT) control mice. Absence of IFNα2A did not affect other members of the IFNα family but it affected IFNβ and IFNγ expressions as well as some immune cells on day 5 PI compared to WT mice. Viral replication in the eye, eye disease, and survival amongst ocularly infected IFNα2A-/- mice were similar to that of WT infected mice. The absence of IFNα2A significantly reduced the levels of latency and T cell exhaustion but not time of reactivation compared with control mice. Our results suggest that blocking IFNα2A expression may be a useful tool in reducing latency and the subsequent side effects associated with higher levels of latency.

References
1.
Luker G, Prior J, Song J, Pica C, Leib D . Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J Virol. 2003; 77(20):11082-93. PMC: 224994. DOI: 10.1128/jvi.77.20.11082-11093.2003. View

2.
Kim Y, Muralinath M, Brandt T, Pearcy M, Hauns K, Lowenhaupt K . A role for Z-DNA binding in vaccinia virus pathogenesis. Proc Natl Acad Sci U S A. 2003; 100(12):6974-9. PMC: 165815. DOI: 10.1073/pnas.0431131100. View

3.
Heim M . 25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end. Nat Rev Immunol. 2013; 13(7):535-42. DOI: 10.1038/nri3463. View

4.
Brierley M, Fish E . Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry. J Interferon Cytokine Res. 2002; 22(8):835-45. DOI: 10.1089/107999002760274845. View

5.
Leib D, Harrison T, Laslo K, Machalek M, Moorman N, Virgin H . Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J Exp Med. 1999; 189(4):663-72. PMC: 2192939. DOI: 10.1084/jem.189.4.663. View